Cellements has developed a strong business model that takes these impressive products from the pharmacies and vaccination clinics to the average consumer through its Direct Selling Partners.
The company has started to accept orders and signups from Partners & Customers in USA:
CEO Anders Karlsson said:
We believe in the biggest Direct Sales Market of the world and also value the historic aspect of that the concept was developed in US.
Our category of products fit into a marketplace where more and more people think about prevention and getting sick is either not an option (you might have to work anyway) or very expensive.
Most companies grow from US into Asia, Latin/South America and other countries from US. We look forward in supporting US leaders in building a global business with Cellements spreading around the globe.
We have several parallel projects regarding the US market running. We are working on setting up an entity in Arizona (estimated to be ready mid May), Working on merchant account after that to accept USD and be able to pay out USD with no currency conversion.
We ordered first 40,000 AntiBac Sprays with FDA complaint label (another active ingredient will be lifted for the US market that is already registered in